Download full-text PDF

Source
http://dx.doi.org/10.1093/asj/sjad322DOI Listing

Publication Analysis

Top Keywords

commentary efficacy
4
efficacy acellular
4
acellular dermal
4
dermal matrix
4
matrix type
4
type treatment
4
treatment capsular
4
capsular contracture
4
contracture breast
4
breast augmentation
4

Similar Publications

Neoadjuvant or perioperative immunotherapy for resectable melanoma: The need for biomarkers.

Eur J Cancer

January 2025

National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. Electronic address:

Groundbreaking studies have reshaped the treatment landscape for patients with resectable stage ≥IIIB melanoma by demonstrating the benefits of neoadjuvant therapy. Data from the NADINA and SWOG S1801 trials reveal substantial improvements in event-free survival compared to adjuvant therapy alone. These studies employed distinct neoadjuvant immunotherapy approaches - ipilimumab plus nivolumab in NADINA and anti-PD-1 monotherapy in SWOG S1801 - highlighting potential differences in efficacy and toxicity.

View Article and Find Full Text PDF

Elegant and Innovative Recoding Strategies for Advancing Vaccine Development.

Vaccines (Basel)

January 2025

Department of Veterinary Microbiology and Immunology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E2, Canada.

Recoding strategies have emerged as a promising approach for developing safer and more effective vaccines by altering the genetic structure of microorganisms, such as viruses, without changing their proteins. This method enhances vaccine safety and efficacy while minimizing the risk of reversion to virulence. Recoding enhances the frequency of CpG dinucleotides, which in turn activates immune responses and ensures a strong attenuation of the pathogens.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!